11/25
08:02 am
crsp
Capsida Biotherapeutics to Present at 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
Low
Report
Capsida Biotherapeutics to Present at 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
11/24
05:52 am
crsp
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]
Medium
Report
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]
11/23
06:40 am
crsp
3 Monster Stocks in the Making [Yahoo! Finance]
Medium
Report
3 Monster Stocks in the Making [Yahoo! Finance]
11/22
09:14 am
crsp
Genome Editing Market Size Projected to Reach USD 32.72 Billion by 2032, Driven by Advances in CRISPR and Gene Therapies – SNS Insider [Yahoo! Finance]
Low
Report
Genome Editing Market Size Projected to Reach USD 32.72 Billion by 2032, Driven by Advances in CRISPR and Gene Therapies – SNS Insider [Yahoo! Finance]
11/20
11:41 am
crsp
The Gene Revolution: Transforming Lives through Gene Editing Therapeutics [Yahoo! Finance]
Low
Report
The Gene Revolution: Transforming Lives through Gene Editing Therapeutics [Yahoo! Finance]
11/17
05:20 pm
crsp
CRISPR Therapeutics AG (CRSP): Among ARK Invest's Top Stock Picks for 2024 [Yahoo! Finance]
Low
Report
CRISPR Therapeutics AG (CRSP): Among ARK Invest's Top Stock Picks for 2024 [Yahoo! Finance]
11/16
06:06 am
crsp
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More [Yahoo! Finance]
Low
Report
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More [Yahoo! Finance]
11/14
08:57 am
crsp
Genome Editing Market Expected To Reach 30.78 Billion 2032, Growing at CAGR 17.18% | Introspective Market Research [Yahoo! Finance]
Medium
Report
Genome Editing Market Expected To Reach 30.78 Billion 2032, Growing at CAGR 17.18% | Introspective Market Research [Yahoo! Finance]
11/14
08:30 am
crsp
CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference
Medium
Report
CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference
11/7
08:08 am
crsp
CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates [Yahoo! Finance]
Low
Report
CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates [Yahoo! Finance]
11/7
08:00 am
crsp
CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
Low
Report
CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
11/7
02:04 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
11/6
11:19 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $53.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $53.00 price target on the stock.
11/6
10:15 am
crsp
CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates [Yahoo! Finance]
Low
Report
CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates [Yahoo! Finance]
11/6
09:30 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Barclays PLC from $59.00 to $55.00. They now have an "equal weight" rating on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Barclays PLC from $59.00 to $55.00. They now have an "equal weight" rating on the stock.
11/6
08:07 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $84.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $84.00 price target on the stock.
11/5
01:04 pm
crsp
VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised [Yahoo! Finance]
Low
Report
VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised [Yahoo! Finance]
11/5
12:13 pm
crsp
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
Low
Report
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
11/5
09:05 am
crsp
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/5
09:01 am
crsp
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
Low
Report
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
11/4
11:43 am
crsp
CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average [Yahoo! Finance]
Low
Report
CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average [Yahoo! Finance]
10/30
07:48 am
crsp
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy [Yahoo! Finance]
Low
Report
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy [Yahoo! Finance]
10/29
11:06 pm
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
10/28
10:45 am
crsp
CRISPR Therapeutics to Report Q3 Earnings: Is a Beat in Store? [Yahoo! Finance]
Low
Report
CRISPR Therapeutics to Report Q3 Earnings: Is a Beat in Store? [Yahoo! Finance]
10/28
06:38 am
crsp
Crispr Therapeutics: Poised For A Major Turnaround [Seeking Alpha]
Medium
Report
Crispr Therapeutics: Poised For A Major Turnaround [Seeking Alpha]